TD Cowen initiated coverage of Intuitive Surgical (ISRG) with a Buy rating and $660 price target The firm initiated six companies in the medical technology space. While Intuitive is a “consensus long,” survey work indicates that the Street is not appreciating the company’s “longer-tailed” and higher procedure volume growth outlook, the analyst tells investors in a research note. TD views Intuitive Surgical as a “must-own, secular growth story.”
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical: Da Vinci 5 Rollout and Secular Procedure Growth Underpin TD Cowen Buy Rating and $660 Target
- Intuitive Surgical upgraded to Buy from Hold at Freedom Capital
- Intuitive Surgical says Da Vinci 5 cleared for cardiac procedures
- Intuitive Surgical price target raised to $712 from $686 at Barclays
- Intuitive Surgical Earnings Call: Growth Surges, Margins Pinched